22483-40-5

Basic information

• Product Name: 4-NITROPHENYL-2-METHOXYETHYL ETHER
• Synonyms: 4-NITROPHENYL-2-METHOXYETHYL ETHER;1-(2-Methoxyethoxy);Benzene, 1-(2-methoxyethoxy)-4-nitro-
• CAS NO: 22483-40-5
• Molecular Formula: C₉H₁₁NO₄
• Molecular Weight: 376.3606
• Mol File: 22483-40-5.mol

Chemical Properties

• Boiling Point: 503.8 °C at 760 mmHg
• Flash Point: 196.2 °C
• Appearance: /
• Density: 1.283 g/cm³
• Vapor Pressure: 0.000736mmHg at 25°C
• Refractive Index: 1.525
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-NITROPHENYL-2-METHOXYETHYL ETHER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-NITROPHENYL-2-METHOXYETHYL ETHER(22483-40-5)
• EPA Substance Registry System: 4-NITROPHENYL-2-METHOXYETHYL ETHER(22483-40-5)

Safety Data

• Hazardous Substances Data: 22483-40-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-NITROPHENYL-2-METHOXYETHYL ETHER is used as a protecting group for alcohols in organic synthesis, facilitating the production of various pharmaceutical compounds. Its ability to shield alcohol groups during chemical reactions allows for selective reactions to occur, enhancing the synthesis process and yielding desired products more efficiently.
Used in Chemical Industry:
In the chemical industry, 4-NITROPHENYL-2-METHOXYETHYL ETHER serves as a crucial component in the synthesis of a range of chemical products. Its function as a protecting group aids in the controlled formation of complex molecules, which is vital for the development of specialty chemicals with specific applications.
Used in Agrochemical Production:
4-NITROPHENYL-2-METHOXYETHYL ETHER is utilized in the production of agrochemicals, where its role as a protecting group in organic synthesis contributes to the creation of effective and targeted agricultural chemicals. This ensures the development of products that can be safely and effectively used in agricultural settings.
Used in Specialty Chemicals:
4-NITROPHENYL-2-METHOXYETHYL ETHER finds application in the realm of specialty chemicals, where its unique properties as a protecting group in organic synthesis reactions are harnessed to produce chemicals with specific, tailored properties for niche applications.

InChI:InChI=1/C9H11NO4/c1-13-6-7-14-9-4-2-8(3-5-9)10(11)12/h2-5H,6-7H2,1H3

Upstream product

• 1124-31-8 potassium 4-nitrophenolate 
• 6482-24-2 2-Bromoethyl methyl ether 
• 100-02-7 4-nitro-phenol 
• 33311-29-4 4-(2-methoxyethoxy)aniline 
• 350-46-9 4-Fluoronitrobenzene 
• 70384-51-9 Tris(3,6-dioxaheptyl)amine 
• 584-08-7 potassium carbonate 
• 109-86-4 2-methoxy-ethanol 

Downstream Products

• 33311-29-4 4-(2-methoxyethoxy)aniline 
• 616882-46-3 [5-(2-methoxy-ethoxy)-2-nitro-benzyl]-trimethyl-silane 
• 1026179-29-2 4-(2-Methoxy-ethoxy)-2-methyl-1-nitro-benzene 
• 927891-86-9 5-(2-methoxyethoxy)-2-nitrobenzaldehyde 
• 616882-45-2 2-chloro-3-{2-[5-(2-methoxy-ethoxy)-2-nitrophenyl]-vinyl}quinoline 
• 616882-47-4 1-(2-chloro-quinolin-3-yl)-2-[5-(2-methoxy-ethoxy)-2-nitro-phenyl]-ethanol 
• 616882-50-9 2-chloro-4-[5-(2-methoxy-ethoxy)-2-nitrobenzyl]-1,4-dihydro-quinolin-3-carboxaldehyde 
• 76663-16-6 2-{[4-(2-methoxyethoxy)phenyl]amino}-N-(4-sulfamoylphenyl)acetamide 
• 76662-79-8 2-{Acetyl-[4-(2-methoxy-ethoxy)-phenyl]-amino}-N-(4-sulfamoyl-phenyl)-acetamide 

Relevant articles and documents

PROPENAMIDE THIOPHENE DERIVATIVES AS FLAVIVIRUS INHIBITORS AND THEIR USE

The present invention deals with new flavivirus inhibitors, compositions comprising said inhibitors and methods for the treatment of disorders related to a viral infection, such as a disease due to a flavivirus infection, comprising administering said inhibitors.

Eeyarestatin I derivatives with improved aqueous solubility

Inhibition of p97 (also known as valosin-containing protein (VCP)), has been validated as a promising strategy for cancer therapy. Eeyarestatin I (EerI) blocks p97 through a novel mechanism of action and has favorable anti-cancer activities against cultured cancer cells. However, its poor aqueous solubility severely limits its in vivo applications. To circumvent this problem, we have identified EerI derivatives that possess improved aqueous solubility by introducing a single solubilizing group. These modified compounds preserved endoplasmic reticulum (ER) stress-inducing and antiproliferative activities as well as generally good in vitro metabolic properties, suggesting that these EerI derivatives could serve as candidates for further optimization.

HETEROCYCLIC COMPOUNDS AND USES THEREOF

The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder, a cancer, a tumor, an inflammatory disease, an autoimmune disease, psoriasis, dry eye or an immunologically related disease, and in some embodiments diseases or disorders related to the dysregulation of kinase such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, FLT3(D835Y), ITK, TEC, TXK, BTK, or JAK, and the respective pathways.

TYK2 INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

INHIBITORS OF BRUTON'S TYROSINE KINASE

Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. In addition, reversible inhibitors of Btk are also described. Also disclosed are pharmaceutical compositions th

Chemokine receptor binding compounds

The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds

1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives

The present invention relates to 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives of the formula: STR1 to their preparation and to the pharmaceutical compositions in which they are present. These derivatives have an affinity for the vasopressin and oxytocin receptors.